| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $61.9M | -0.4% |
| Cost of Revenue | $64.4M | +8.2% |
| Gross Profit | -$2.4M | -188.8% |
| R&D Expense | $6.8M | -3.6% |
| SG&A Expense | $15.3M | -5.2% |
| Operating Income | -$30.3M | -6.7% |
| Interest Expense | $2.4M | +25.6% |
| Income Tax | $0 | — |
| Net Income | -$32.7M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.3M | -72.7% |
| Accounts Receivable | $5.9M | +41.8% |
| Inventory | $4.1M | +4.2% |
| Current Assets | $35.3M | -49.2% |
| Total Assets | $48.6M | -37.5% |
| Current Liabilities | $21.0M | +63.9% |
| Long-term Debt | $13.2M | -37.1% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.5M | -13.1% |
| Investing Cash Flow | $311K | -90.3% |
| Financing Cash Flow | -$2.2M | -103.4% |
| -5.8% |
| EPS (Basic) | -$0.35 | +14.6% |
| EPS (Diluted) | -$0.35 | +14.6% |
| Total Liabilities |
| $46.0M |
| +5.6% |
| Stockholders' Equity | $2.5M | -92.6% |